Influence of Prostate Volume and Percent Free Prostate Specific Antigen on Prostate Cancer Detection in Men With a Total Prostate Specific Antigen of 2.6 to 10.0 ng/ml

Journal of Urology

Volumn 177, Issue 5, 2007, Pages 1741-1744

  Bruno II, J James ^a   Armenakas, Noel A ^a   Fracchia, John A ^a  

^a LENOX HILL HOSPITAL   (United States)

Author keywords

prostate; prostate specific antigen; prostatic hyperplasia; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SCREENING; DIGITAL RECTAL EXAMINATION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; ORGAN SIZE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE VOLUME; RISK FACTOR; TRANSRECTAL ULTRASONOGRAPHY;

AGED; BIOPSY; DIAGNOSIS, DIFFERENTIAL; ENDOSONOGRAPHY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TUMOR MARKERS, BIOLOGICAL;

EID: 34147176134     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.01.067     Document Type: Article

References (14)

1. Benson M.C., Whang I.S., Pantuck A., Ring K., Kaplan S.A., Olsson C.A., et al. Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol 147 (1992) 815
2. Catalona W.J., Smith D.S., Wolfert R.L., Wang T.J., Rittenhouse H.G., Ratliff T.L., et al. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA 274 (1995) 1214
3. Catalona W.J., Partin A.W., Slawin K.M., Brawer M.K., Flanigan R.C., Patel A., et al. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. JAMA 279 (1998) 1542
4. Morote J., Raventos C.X., Lorente J.A., Lopez-Pacios M.A., Encabo G., de Torres I., et al. Comparison of percent free prostate specific antigen and prostate specific antigen density as methods to enhance prostate specific antigen specificity in early prostate cancer detection in men with normal rectal examination and prostate specific antigen between 4.1 and 10 ng./ml. J Urol 158 (1997) 502
5. Catalona W.J., Beiser J.A., and Smith D.S. Serum free prostate specific antigen and prostate specific antigen density measurements for predicting cancer in men with prior negative prostatic biopsies. J Urol 158 (1997) 2162
6. Krumholtz J.S., Carvalhal G.F., Ramos C.G., Smith D.S., Thorson P., Yan Y., et al. Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor features. Urology 60 (2002) 469
7. Thompson I.M., Pauler D.K., Goodman P.J., Tangen C.M., Lucia M.S., Parnes H.L., et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. N Engl J Med 350 (2004) 2239
8. Catalona W.J., Smith D.S., and Ornstein D.K. Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/ml and benign prostate examination: enhancement of specificity with free PSA measurements. JAMA 277 (1997) 1452
9. Haese A., Chun K.-H.F., Graefen M., Huland E., and Huland H. Age- and percent free PSA stratified risk analysis for prostate cancer detection in men with a total serum PSA 2-4 ng/ml and benign digital rectal examination. J Urol 171 suppl. (2004) 332 abstract 1260.
10. Cooner W.H., Mosley B.R., Rutherford Jr. C.L., Beard J.H., Pond H.S., Terry W.J., et al. Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J Urol 143 (1990) 1146
11. Oesterling J.E., Jacobsen S.J., Chute C.G., Guess H.A., Girman C.J., Panser L.A., et al. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA 270 (1993) 860
12. Carter H.B., Pearson J.D., Waclawiw Z., Metter E.J., Chan D.W., Guess H.A., et al. Prostate-specific antigen variability in men without prostate cancer: effect of sampling interval on prostate-specific antigen velocity. Urology 45 (1995) 591
13. Smith D.S., and Catalona W.J. Rate of change in serum prostate specific antigen levels as a method for prostate cancer detection. J Urol 152 (1994) 1163
14. Isom-Batz G., Basillote J., Pareek G., Rivera A.C., Armenakas N.A., and Fracchia J.A. Size matters! Simple, reliable assessment of prostate volume. J Urol 169 suppl. (2003) 461 abstract 1729.